an increased rate of malignant lymphoma, especially in the small intestine, and that detection of celiac disease may occur before or after the diagnosis of lymphoma. Epithelial lymphocytosis is often evident in these celiac disease patients -particularly in gastric, colonic and/or biliary tract mucosa -and other immune-mediated disorders may be present, including dermatitis herpetiformis and thyroiditis. Finally, common malignant neoplastic epithelial lesions often found in other gastrointestinal sites, such as the esophagus, stomach and colorectum, were not detected in adult celiac disease patients.
PATIENTS AND METHODS
From January 1982 to December 1994 inclusive, 100 patients with adult celiac disease were followed; 35 were initially diagnosed during or after their seventh decade at the University of British Columbia Hospital, Vancouver, British Columbia. All except four of these 35 patients have been followed and reviewed on an annual basis in an adult celiac disease clinic, first established in 1982. One of the four patients died of pneumonia six months after the initial diagnosis while two others died of metastatic ovarian and breast carcinoma four and nine months after the initial diagnosis of celiac disease, respectively. The fourth patient died about one month after celiac disease was diagnosed with progressive liver failure. Four other patients, each followed for over one year, died of lymphoma during the past 13 years, including two patients previously reported elsewhere (8, 9) . One other patient, recently reported (10), died of an extensive duodenal adenocarcinoma, while another died of metastatic ovarian carcinoma about 16 months after diagnosis of celiac disease.
Office and hospital records of all patients were reviewed. Details of clinical presentation and past medical history were recorded as well as hematological (hemoglobin, white blood cell count, platelet count, peripheral blood smear) and biochemical results (carotene, iron and iron binding capacity, folic acid, vitamin B12, calcium, phosphate, total protein, albumin, prothrombin time, immunoglobulin quantitation, amylase, and thyroid and liver chemistry tests). After biopsies of the small intestine were done, patients were reviewed by a clinical dietitian with a special interest in celiac disease who provided specific instructions on the gluten-free diet. Patients were reviewed periodically as required to address any concerns regarding diet treatment.
Compliance and response to a prescribed strict gluten-free diet were assessed during each clinic visit.
Each of the 35 patients had a severely abnormal 'flat' small intestinal biopsy (so-called crypt hyperplastic villous atrophy) obtained before institution of a gluten-free diet (7) . In 34 patients, initial biopsies were severely abnormal and treatment was initiated within two weeks. In one patient with small bowel lymphoma, reported elsewhere (8), multiple small intestinal biopsies on a high gluten diet were required to demonstrate the typical histological features of adult celiac disease. Biopsies from at least two separate sites in the small intestine in each patient were obtained with at least one biopsy from a site distal to the descending duodenum. Biopsies were also obtained from the gastric mucosa, usually the anatomical prepyloric gastric antrum, lesser curvature. Finally, at least one colorectal biopsy was obtained from all patients, usually from a valve in the distal 25 cm, using either a fibreoptic flexible sigmoidoscope or colonoscope. In 34 patients, biopsies of the small intestine were repeated after at least eight weeks to determine whether a histological response to a gluten-free diet had occurred. In one patient with a small bowel adenocarcinoma (10), biopsies were repeated after hospitalization for six weeks on a gluten-free diet in a clinical investigation unit setting to ensure compliance.
For diagnosis of lymphoma, surgically resected specimens or biopsy material from the small intestine or lymph nodes were used. In four of five patients with lymphoma or small intestinal adenocarcinoma who died, additional histological materials were obtained from autopsies.
RESULTS

Types and frequencies of neoplastic complications:
The types and frequencies of neoplastic disorders in the 35 elderly celiac disease patients initially diagnosed after age 60 years are listed in Table 1 . No malignant neoplasms have been detected in the 65 adult celiac disease patients initially diagnosed before age 60 years. Ten of the 35 patients (almost 30%) with adult celiac disease initially diagnosed after age 60 years had a lymphoma or a small intestinal adenocarcinoma. Five of these patients died, four with lymphomas and one with a small bowel adenocarcinoma; all were in their eighth or ninth decade. Three other patients with adult celiac disease diagnosed after age 60 years had malignant disorders; two had metastatic ovarian carcinoma and one had metastatic breast carcinoma. All of these patients died within two years of diagnosis of the malignant disorder. Although a single colon adenoma was detected, invasive epithelial malignant disease was not detected in any other gastrointestinal site, including the esophagus, stomach or colorectum. Small intestinal and/or nodal lymphoma: Six of the eight patients with a lymphoma in this group of 35 elderly adult celiacs (ie, 23% of elderly celiac disease patients or 8% of the 100 adult celiac disease patients from this single hospital) had small intestinal involvement, including two with nodal disease in extra-abdominal sites (tonsillar and retroperitoneal nodes). Two lymphoma patients had nodal involvement only (inguinal and cervical nodes) without small intestinal lymphoma. In four patients, lymphoma was confined to the small intestine (in at least one site). In one patient, multifocal small intestinal involvement was present (8) . As shown in Table 2 , any site within the small intestine can be involved; in this group of eight patients with lymphoma, however, lymphoma was most commonly detected in the jejunum. Associated gastrointestinal findings: Common clinical disorders associated with adult celiac disease are shown in Table  2 . These included epithelial lymphocytosis as lymphocytic gastritis (11) in three patients, lymphocytic colitis (12) in two patients and lymphocytic sclerosing cholangitis (13) in one patient. In addition, cavitated mesenteric lymph nodes associated with splenic hypofunction were detected in two patients with lymphoma who died; one was previously reported in detail elsewhere as the first case of mesenteric lymph node cavitation syndrome and hyposplenism complicated by lymphoma (9) . Associated nongastrointestinal findings: In this series of 10 patients with lymphoma or small bowel adenocarcinoma, dermatitis herpetiformis was reported in four patients (40%), and confirms observations from a previous study from a different hospital of seven patients with lymphoma and clinically occult celiac disease, some with dermatitis herpetiformis (3). In addition, a high frequency of thyroid disease was detected (14) . Four of 10 patients (40%) with either lymphoma or small bowel adenocarcinoma had hypothyroidism (based on low serum thyroxine, elevated thyroid-stimulating hormone or both) accompanied by positive thyroid antibodies most typical of thyroiditis. Interestingly, three of the four patients shared common clinicopathological features of dermatitis herpetiformis, thyroiditis, hypothyroidism, epithelial lymphocytosis (gastric, colonic and/or biliary tract) and celiac disease. While this relationship has not been previously described, it may reflect, in part, the observation (15) that the incidence of thyroid disease, particularly hypothyroidism associated with increased titres of thyroid antibodies, increases with advancing age. Alternatively, this may represent a distinct clinical and pathological subset of patients with celiac disease who have an associated multisystem syndrome characterized by increased numbers of intraepithelial lymphocytes at other sites in the gastrointestinal tract as well as skin and thyroid epithelium.
Other gastrointestinal neoplasms:
The absence of other neoplastic disorders in the gastrointestinal tract in this elderly population was an unexpected finding. Moreover, only two patients had preneoplastic epithelial disorders: one had a colonic adenoma and one had a Barrett's esophagus. The detection of a single colonic adenoma in an elderly population with a late diagnosis of celiac disease has special significance because the patients in the present study had, as a minimum, a limited endoscopic examination of the distal colon (ie, flexible sigmoidoscopy) and colorectal biopsy. Similarly, the failure to observe Barrett's type mucosa during upper endoscopic studies was surprising because the latter may be expected to occur more frequently in a patient population reported elsewhere to have an increased risk of esophageal cancer (4) .
DISCUSSION
This study explored the frequencies of different types of malignant disorders detected in a population of 100 celiac disease patients seen consecutively at a single teaching hospital. Diagnosis of celiac disease was based on characteristic histological features and response to a gluten-free diet. The overall incidence of lymphoma in the present report was 8%, comparable with observations in several other large series of celiac disease patients (16) (17) (18) (19) (20) (21) . However, this increased risk was due entirely, at least in the author's experience, to the fact that patients with celiac disease were diagnosed after age 60 years. In the 35 elderly celiac patients, the incidence of lymphoma was 23%; if patients with small intestinal adenocarcinoma were also included, almost 30% of patients with celiac disease initially diagnosed after age 60 were affected by one of these two malignancies. To date, patients diagnosed with celiac disease before age 60 years have not developed a malignant complication. This suggests that the risk of lymphoma development may be more substantial if the diagnosis is initially made later in life, possibly because of continued consumption of gluten-containing foods until diagnosis of celiac disease and institution of a gluten-free diet. This observation provides additional indirect evidence that treatment with a strict gluten-free diet with resultant normalization of the small intestinal mucosa in patients with celiac disease may be critical for prevention of lymphoma and, pos- sibly, other small intestinal disorders such as adenocarcinoma.
Lymphomas in the celiac disease patients studied in the present report were usually located in the small intestine; in some patients, diagnosis of celiac disease was established before subsequent development of lymphoma, while in others the celiac disease was clinically occult and was diagnosed following presentation with lymphoma. These findings confirm observations from other centres, including a previous report from another Canadian teaching hospital (3). In addition, the present study confirms previous reports that have described detection of celiac disease in patients with a previously diagnosed extra-intestinal site of lymphoma (22, 23) .
Two patients reported here had a nodal lymphoma diagnosed without evidence of small intestinal lymphoma. The first was an 81-year-old female in whom lymphoma was diagnosed in 1991 after removal of a cervical node. In 1993 she developed weight loss, and celiac disease was diagnosed. After treatment with a gluten-free diet she regained the weight. In 1995 she remained well with no evidence of recurrent lymphoma. The second patient was a 60-year-old male with long-standing dermatitis herpetiformis in whom a localized lymphoma was detected in an enlarged right inguinal lymph node in 1976. He was treated with chemotherapy and radiation; no recurrent lymphoma was observed. In 1992 lymphocytic sclerosing cholangitis (13) and celiac disease were detected. Others in this series had nodal involvement, but in these patients there was an associated small intestinal lymphoma. In lymphoma patients with chronic diarrhea or weight loss, recurrent lymphoma or the effects of lymphoma treatment may be considered. Because of nutritional implications, however, concomitant clinically occult celiac disease also requires exclusion.
Especially intriguing was the remarkable absence of malignant disease elsewhere in the gastrointestinal tract in these 35 elderly celiac patients (and in the entire series of 100 adult celiac disease patients). Except for a single patient with the hypothesized preneoplastic esophageal lesion (ie, Barrett's mucosa), esophageal carcinoma was not detected despite complete upper endoscopic examinations. This finding differs from observations reported from other centres, particularly the United Kingdom, suggesting that pharyngeal and esophageal carcinomas are common in celiac disease patients (4, 5, 16) . This may reflect exposure to different environmental factors in Canada compared with other countries. In addition, only one patient in this study had a colonic adenoma detected; no colonic cancer has been detected in any of the other celiac disease patients in this series. This seems to be consistent with the reported, but underemphasized, clinical experience from other centres (5, (24) (25) (26) .
A much higher incidence of both benign and malignant colonic neoplastic lesions (as well as breast carcinoma) should have been detected, particularly in the elderly patients. Perhaps untreated celiac disease is protective; dietary fat or fat soluble agents, including hydrocarbons or other putative cocarcinogens, that have been implicated in the pathogenesis of both colonic and breast carcinoma may be poorly absorbed and rapidly excreted. Alternatively, the immunological alterations (eg, epithelial lymphocytosis) in celiac disease may protect these patients from malignant diseases at other gastrointestinal sites. Additional studies are needed to elucidate further this observation in celiac disease patients.
